The glucagon-like peptide 1 receptor (GLP-1r), which has become an important target in the treatment of type 2 diabetes [4], is emerging as a potential target for such probes, because of its high expression in beta cells [5]. Here, GLP1R is linked to type 2 diabetes mellitus.